Collin Price, MD
| Dr. Collin M. Price is a dedicated psychiatrist at UCLA, currently engaged in advanced training as a Max Gray Fellow in the Mood Disorders Clinic at the Semel Institute for Neuroscience and Human Behavior. His clinical focus includes the treatment of complex mood disorders, with a particular interest in neuromodulation techniques and psychedelic-assisted psychotherapy.
Dr. Price earned his MD from the David Geffen School of Medicine at UCLA, where he also completed his psychiatry residency. His extensive training includes concentrations in neuromodulation, psychodynamic psychotherapy, and clinician education. Throughout his career, Dr. Price has been actively involved in pioneering research, particularly in the emerging field of psychedelics in psychiatry. He has played significant roles in planning and executing clinical trials, including those involving MDMA-assisted psychotherapy for PTSD. In addition to his clinical and research responsibilities, Dr. Price is a committed educator and leader. He founded the Psychedelic Psychiatry Interest Group at UCLA, organized courses, and hosted numerous talks and workshops. His contributions to the field are reflected in his numerous publications and presentations at national and international conferences. Dr. Price’s work is recognized with various honors, including the ISCTM New Investigator Award. His commitment to advancing psychiatric care, particularly in the areas of neuromodulation and psychedelic therapy, positions him as a significant figure in the field. |
American Physician
